Placental protein 13 (galectin-13) has decreased placental expression but increased shedding and maternal serum concentrations in patients presenting with preterm pre-eclampsia and HELLP syndrome.
about
A primate subfamily of galectins expressed at the maternal-fetal interface that promote immune cell deathGalectins: guardians of eutherian pregnancy at the maternal-fetal interfacePlacental Protein 13 (PP13) - A Placental Immunoregulatory Galectin Protecting PregnancyGalectins: Double-edged Swords in the Cross-roads of Pregnancy Complications and Female Reproductive Tract Inflammation and NeoplasiaPP13, maternal ABO blood groups and the risk assessment of pregnancy complicationsNoninvasive in vivo monitoring of tissue-specific global gene expression in humans.Characteristic Changes in Decidual Gene Expression Signature in Spontaneous Term Parturition.Genetic aspects of preeclampsia and the HELLP syndrome.The role of the carbohydrate recognition domain of placental protein 13 (PP13) in pregnancy evaluated with recombinant PP13 and the DelT221 PP13 variantEvolutionary origins of the placental expression of chromosome 19 cluster galectins and their complex dysregulation in preeclampsia.Preeclampsia from a renal point of view: Insides into disease models, biomarkers and therapy.In vivo experiments reveal the good, the bad and the ugly faces of sFlt-1 in pregnancy.Placental extracellular vesicles and feto-maternal communication.Full-length human placental sFlt-1-e15a isoform induces distinct maternal phenotypes of preeclampsia in mice.Transcriptionally active syncytial aggregates in the maternal circulation may contribute to circulating soluble fms-like tyrosine kinase 1 in preeclampsia.Maternal plasma concentrations of angiogenic/anti-angiogenic factors are of prognostic value in patients presenting to the obstetrical triage area with the suspicion of preeclampsia.Late-onset preeclampsia is associated with an imbalance of angiogenic and anti-angiogenic factors in patients with and without placental lesions consistent with maternal underperfusion.Placental protein 13 (PP13/galectin-13) undergoes lipid raft-associated subcellular redistribution in the syncytiotrophoblast in preterm preeclampsia and HELLP syndrome.Microarray profiling reveals that placental transcriptomes of early-onset HELLP syndrome and preeclampsia are similar.Changes of placental syndecan-1 expression in preeclampsia and HELLP syndrome.Preeclampsia and ABO blood groups: a systematic review and meta-analysis.Physiological and pathophysiological roles of placental aminopeptidase in maternal sera: possible relation to preeclampsia and preterm delivery.A potential pathophysiological role for galectins and the renin-angiotensin system in preeclampsia.Towards molecular mechanisms regulating the expression of galectins in cancer cells under microenvironmental stress conditions.Resolution of inflammation pathways in preeclampsia-a narrative review.Personalized Therapy Against Preeclampsia by Replenishing Placental Protein 13 (PP13) Targeted to Patients With Impaired PP13 Molecule or Function.First trimester prediction of HELLP syndrome.Immunological Tolerance, Pregnancy, and Preeclampsia: The Roles of Semen Microbes and the Father.Activation of villous trophoblastic p38 and ERK1/2 signaling pathways in preterm preeclampsia and HELLP syndrome.The Role of Galectins as Modulators of Metabolism and Inflammation.Pharmacokinetics of placental protein 13 after intravenous and subcutaneous administration in rabbits.Integrated Systems Biology Approach Identifies Novel Maternal and Placental Pathways of Preeclampsia
P2860
Q24317162-FD7AEAC7-0A8C-4494-B581-3A6E7A079212Q26823092-2979CA2C-6897-492D-BC5C-CA7AC72D928DQ26861380-5FFE468F-05A4-4333-9769-A5D03DC31916Q28081459-696E7084-B923-4B5A-8E10-E80EBCE43874Q28742192-E13EA220-CE8F-475D-AF04-E7EECC65589EQ33665478-2C92C55C-FED2-41A7-A5B0-B6E44D6CF60AQ33729663-D335748E-612C-49D1-BC91-CC8178D7F143Q33766563-7A55F000-C434-4EE1-BC5C-A567568AF817Q33981931-20628EFB-16E0-4EA7-B158-EE130F55C6B1Q34372600-C1F2A93F-84ED-4C11-A4FC-67C4713A3D3FQ34453242-D3B9C6DC-218A-4554-99DB-F9B6947713CDQ34505704-D4BBFAE4-EC29-44C0-A455-6EB25D6F633FQ35164277-71F10E2A-CF6F-4EA2-AD61-33658ACAD45EQ35362708-483FC1CB-058E-416B-827A-B7B95E82D476Q35871466-49190645-70AE-470D-AC6F-234BFB37899DQ36062460-AD487097-B42E-4206-A82D-D98519B4D2BDQ36107337-CA7FABBB-A25B-41CD-B1EB-C2A3C77DA3CDQ36480074-CA9EBA75-4386-4EEB-9731-7F3FBD1A6333Q37567589-7DF7E968-9ED3-4AE4-86A6-970E7345FF11Q37612423-E5FAC906-64F4-4154-9668-AC2DDA218E0DQ38062833-648C7D2D-54A7-426B-A912-368A9C8A486FQ38089817-1D119F35-BC90-4340-A021-A846834B1CA8Q38246351-3C617464-A2E6-41C4-B0F2-33BBAEFA92F3Q38561302-FEDC8001-8A4F-4C58-B7D8-90B3FC9C5835Q39229350-71AA25F7-EE01-4EE9-8C1B-7E00E1816F91Q42373442-B74067D8-3FAE-4F5F-AC1D-3974C18AC926Q46169022-6E37AA2A-7BE0-4338-951C-D6E8E92A7784Q47550799-3D547955-F235-4218-B35A-A90866AC79AAQ53639289-4F1B9132-C9A5-4C2B-9058-F839BD961DB3Q55349770-240DA201-47FF-4B49-8362-2EDFE49B4DC4Q55692173-CEFE196C-FBA7-4137-8173-43E49E78428EQ58795465-A00DFB81-203F-4109-B077-59375DC8BCB3
P2860
Placental protein 13 (galectin-13) has decreased placental expression but increased shedding and maternal serum concentrations in patients presenting with preterm pre-eclampsia and HELLP syndrome.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 13 September 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Placental protein 13 (galectin ...... -eclampsia and HELLP syndrome.
@en
Placental protein 13
@nl
type
label
Placental protein 13 (galectin ...... -eclampsia and HELLP syndrome.
@en
Placental protein 13
@nl
prefLabel
Placental protein 13 (galectin ...... -eclampsia and HELLP syndrome.
@en
Placental protein 13
@nl
P2093
P2860
P1433
P1476
Placental protein 13 (galectin ...... e-eclampsia and HELLP syndrome
@en
P2093
Adi L Tarca
Balint Nagy
Beata Hargitai
Gabor Szabo
Hamutal Meiri
Ilona Kovalszky
Istvan Sziller
Janos Rigo
Marei Sammar
Nandor Gabor Than
P2860
P2888
P304
P356
10.1007/S00428-008-0658-X
P577
2008-09-13T00:00:00Z